What does Canid do?
Canid is a NYC-based healthcare technology company that supports pediatric vaccine management by turning the complex process of vaccine administration into a simple scan-and-go workflow. The platform integrates with electronic health record systems and leverages AI, software, and economies of scale.
How much did they raise?
The company raised $10M in a Series A funding round led by Telescope Partners, with participation from FJ Labs, Brooklyn Bridge Ventures, and SeedtoB. This round increased Canid's total funding to $12.9M.
What are their plans for the money?
Canid plans to use the funds to accelerate its expansion and development efforts, potentially leading to broader adoption of its efficient vaccine management technology and relief for pediatric practices in handling administrative tasks.
What have they achieved so far?
The company has already achieved significant progress by integrating its platform with electronic health records and streamlining the vaccine lifecycle, reducing both time and costs for pediatricians.
